Free Trial
OTCMKTS:VASO

Vaso (VASO) Stock Price, News & Analysis

Vaso logo
$0.29 -0.01 (-1.86%)
As of 10/30/2026 01:10 PM Eastern

About Vaso Stock (OTCMKTS:VASO)

Advanced

Key Stats

Today's Range
$0.29
▼
$0.29
50-Day Range
$0.28
▼
$0.31
52-Week Range
$0.11
▼
$0.34
Volume
45,000 shs
Average Volume
82,132 shs
Market Capitalization
$50.30 million
P/E Ratio
28.54
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vaso Corporation is a healthcare technology and medical equipment company that has operated through businesses serving the diagnostic imaging, healthcare information technology and cardiovascular care markets. The company has been headquartered in Plainview, New York, and has historically served customers in the United States, particularly hospitals, physician practices and other non-hospital healthcare providers.

Through its VasoHealthcare business, Vaso historically marketed and provided sales and service support for diagnostic imaging equipment, including products supplied by GE Healthcare, to non-hospital healthcare organizations. Its VasoTechnology operations focused on healthcare information technology, including software and related solutions designed to support medical imaging, clinical workflows and the management of healthcare data.

Vaso’s VasoDiagnostics business has been associated with medical devices and services for cardiovascular care, including enhanced external counterpulsation systems and other technologies used in the treatment and evaluation of cardiovascular conditions. The company has been led by Jun Ma, who has served as its chief executive officer. Vaso Corporation was formerly known as Vasomedical, Inc. and adopted its current name as it expanded its focus beyond cardiovascular medical devices.

AI Generated. May Contain Errors.

Vaso Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

VASO MarketRank™: 
1.634941329855 of 5 stars

Vaso scored higher than 33% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Vaso.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vaso is 28.57, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.95.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vaso is 28.57, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.77.

  • Price to Book Value per Share Ratio

    Vaso has a P/B Ratio of 1.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.00% of the float of Vaso has been sold short.
  • Short Interest Ratio / Days to Cover

    Vaso has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vaso has recently decreased by 80.67%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Vaso does not currently pay a dividend.

  • Dividend Growth

    Vaso does not have a long track record of dividend growth.

  • News Sentiment

    Vaso has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Vaso this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Vaso insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    43.85% of the stock of Vaso is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Vaso has minimal institutional ownership at this time.

  • Read more about Vaso's insider trading history.
Receive VASO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vaso and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VASO Stock News Headlines

Vaso Corporation (OTCMKTS:VASO) Stock Short Interest Falls 80.7%
Why Gerardo Del Real says wait before buying uranium stocks
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before. In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years. Del Real just released a full video breakdown of what is driving this move and how to prepare.tc pixel
See More Headlines

VASO Stock Analysis - Frequently Asked Questions

Vaso's stock was trading at $0.1749 on January 1st, 2026. Since then, VASO shares have increased by 63.2% and is now trading at $0.2854.

Vaso Corporation (OTCMKTS:VASO) released its quarterly earnings results on Friday, May, 15th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business earned $19.36 million during the quarter. Vaso had a net margin of 3.11% and a trailing twelve-month return on equity of 9.68%.

Shares of VASO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vaso investors own include GoPro (GPRO), TG Therapeutics (TGTX), Bristol Myers Squibb (BMY), Tyson Foods (TSN), Advantage Energy (AAVVF), Adobe (ADBE) and Agios Pharmaceuticals (AGIO).

Company Calendar

Last Earnings
5/15/2026
Today
11/01/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:VASO
CIK
839087
Employees
282
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.01
Trailing P/E Ratio
28.54
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.57 million
Net Margins
3.11%
Pretax Margin
-0.59%
Return on Equity
9.68%
Return on Assets
3.27%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.68
Quick Ratio
1.65

Sales & Book Value

Annual Sales
$89.10 million
Price / Sales
0.56
Cash Flow
$0.04 per share
Price / Cash Flow
7.11
Book Value
$0.17 per share
Price / Book
1.68

Miscellaneous

Outstanding Shares
176,240,000
Free Float
102,112,000
Market Cap
$50.30 million
Optionable
Not Optionable
Beta
0.65
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (OTCMKTS:VASO) was last updated on 10/30/2026 by MarketBeat.com Staff.
From Our Partners